220
Participants
Start Date
October 20, 2022
Primary Completion Date
July 11, 2024
Study Completion Date
July 11, 2024
ceftazidime avibactam group
Non-Interventional Study
Huashan Hospital Fudan University, Shanghai
Beijing Tsinghua Changgung Hospital, Beijing
Xiangya Hospital Central South University, Changsha
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou
The First affiliated Hospital of Anhui Medical University, Hefei
The First Affiliated Hospital of Nanchang University, Nanchang
Zhongda Hospital Southeast University, Nanjing
The Affiliated People's Hospital of Ningbo University, Ningbo
Shanghai Tenth People's Hospital, Shanghai
The Second People's Hospital of Hebei Medical University, Shijiazhuang
The Third Hospital of Hebei Medical University, Shijiazhuang
The First Affiliated Hospital of Soochow University, Suzhou
Tianjin Medical University General Hospital, Tianjing
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
Henan Provincial People's Hospital, Zhengzhou
Lead Sponsor
Pfizer
INDUSTRY